MetLife Investment Management’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $345K | Buy |
|
|||||
|
2025
Q2 | $572K | Buy |
|
|||||
|
2025
Q1 | $408K | Sell |
|
|||||
|
2024
Q4 | $349K | Buy |
|
|||||
|
2024
Q3 | $425K | Hold |
|
|||||
|
2024
Q2 | $249K | Buy |
|
|||||
|
2024
Q1 | $141K | Hold |
|
|||||
|
2023
Q4 | $75.5K | Hold |
|
|||||
|
2023
Q3 | $52.1K | Hold |
|
|||||
|
2023
Q2 | $92.4K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $90.8K | Buy |
|
|||||
|
2021
Q2 | $171K | Hold |
|
|||||
|
2021
Q1 | $241K | Buy |
|